Ramón Salazar

32.6k total citations · 5 hit papers
249 papers, 13.3k citations indexed

About

Ramón Salazar is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ramón Salazar has authored 249 papers receiving a total of 13.3k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Oncology, 64 papers in Pathology and Forensic Medicine and 62 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ramón Salazar's work include Colorectal Cancer Treatments and Studies (97 papers), Genetic factors in colorectal cancer (61 papers) and Neuroendocrine Tumor Research Advances (45 papers). Ramón Salazar is often cited by papers focused on Colorectal Cancer Treatments and Studies (97 papers), Genetic factors in colorectal cancer (61 papers) and Neuroendocrine Tumor Research Advances (45 papers). Ramón Salazar collaborates with scholars based in Spain, United Kingdom and United States. Ramón Salazar's co-authors include Josep Tabernero, Kjell Öberg, René Bernards, Roderick L. Beijersbergen, Federica Di Nicolantonio, Anirudh Prahallad, Alberto Bardelli, Sidong Huang, Davide Zecchin and Chong Sun and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Ramón Salazar

242 papers receiving 13.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR

2012 1.5k citations Ramón Salazar, René Bernards et al. profile →
Gastroenteropancreatic neuroendocrine tumours

2008 1.2k citations Gregory Kaltsas, Ramón Salazar et al. profile →
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site

2016 738 citations Jaume Capdevila, Ramón Salazar et al. Neuroendocrinology profile →
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2020 736 citations Guillem Argilés, Josep Tabernero et al. profile →
ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary

2012 616 citations Ramón Salazar et al. Neuroendocrinology profile →

Peers

Countries citing papers authored by Ramón Salazar

Since Specialization

Citations

This map shows the geographic impact of Ramón Salazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramón Salazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramón Salazar more than expected).

Fields of papers citing papers by Ramón Salazar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramón Salazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramón Salazar. The network helps show where Ramón Salazar may publish in the future.

Co-authorship network of co-authors of Ramón Salazar

This figure shows the co-authorship network connecting the top 25 collaborators of Ramón Salazar. A scholar is included among the top collaborators of Ramón Salazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramón Salazar. Ramón Salazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Controversies in NEN : An ENETS position statement on the treatment of patients with Grade 3 well‐differentiated neuroendocrine tumours of the gastro‐enteropancreatic tract 2025 ·Journal of Neuroendocrinology ·Mairéad G. McNamara, Halfdan Sørbye, Nehara Begum, Emanuel Christ, Nicola Fazio, Lynnette Fernandez‐Cuesta, Rocio García‐Carbonero, Gregory Kaltsas, Atsuko Kasajima, Ramón Salazar, Ernst‐Jan M. Speel, Andreas Kjær	1
2	A phase II open‐label study with atezolizumab (atezo) in combination with bevacizumab (bev) in patients (pts) with advanced chemotherapy-resistant colorectal cancer (CRC) and MSI‐like molecular signature: The MoTriColor Consortium CT3 study. 2024 ·Journal of Clinical Oncology ·Élena Elez, Salvatore Siena, Andrea Sartore‐Bianchi, Fortunato Ciardiello, Erika Martinelli, Sabine Tejpar, (unknown), Andrés Cervantes, Ramón Salazar, (unknown), (unknown), Sanne C.F.A. Huijberts, (unknown), (unknown), (unknown), Gaetan de Schaetzen, Vı́ctor Moreno, René Bernards, Rodrigo Dienstmann, Josep Tabernero	2
3	Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer 2023 ·Cancers ·Ferrán Moratalla-Navarro, Anna Díez-Villanueva, (unknown), Adrià Closa, David Cordero, Xavier Solé, Elisabet Guinó, Rebeca Sanz‐Pamplona, Xavier Sanjuán, Cristina Santos, Sebastiano Biondo, Ramón Salazar, Vı́ctor Moreno	3
4	Streptozotocin, 1982–2022: Forty Years from the FDA’s Approval to Treat Pancreatic Neuroendocrine Tumors 2022 ·Neuroendocrinology ·Jaume Capdevila, Michel Ducreux, Rocio García‐Carbonero, Enrique Grande, Þorvarður R. Hálfdánarson, (unknown), Salvatore Tafuto, Staffan Welin, Vicente Valentí, Ramón Salazar	22
5	Use of information and communication technologies (ICTs) in cancer multidisciplinary team meetings: an explorative study based on EU healthcare professionals 2022 ·BMJ Open ·Joan Prades, (unknown), Lissandra Dal Lago, Karolien Goffin, (unknown), (unknown), Johan De Munter, Jordi Ponce, Daniele Regge, Ramón Salazar, Vincenzo Valentini, Josep M. Borràs	6
6	Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer 2022 ·British Journal of Cancer ·Alessio Cortellini, Ramón Salazar, Mark Bower, Ailsa Sita-Lumsden, Andrea Plaja, Alvin Lee, Alexia Bertuzzi, Carlo Tondini, Nikolaos Diamantis, Clara Martínez-Vila, Aleix Prat, (unknown), Alessandra Gennari, David J. Pinato	5
7	Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer 2021 ·Clinical Cancer Research ·Laëtitia Marisa, Yuna Blum, Julien Taı̈eb, Mira Ayadi, Camilla Pilati, Karine Le Malicot, Côme Lepage, Ramón Salazar, Daniela Aust, Alex Duval, Hélène Blons, Valérie Taly, David Gentien, Audrey Rapinat, Janick Sèlves, Sophie Mouillet‐Richard, Valérie Boige, Jean‐François Emile, Aurélien de Reyniès, Pierre Laurent‐Puig	37
8	Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death 2021 ·Blood ·(unknown), Suresh Peddigari, Carol A. Mercer, (unknown), (unknown), (unknown), Virginia Amador, Sarah T. Diepstraten, Gemma L. Kelly, Ramón Salazar, Sara C. Kozma, Eric Kusnadi, Jian Kang, Antonio Gentilella, Richard B. Pearson, George Thomas, Joffrey Pelletier	17
9	The 40 S -LARP1 complex reprograms the cellular translatome upon mTOR inhibition to preserve the protein synthetic capacity 2021 ·Science Advances ·Pedro Juan Barrios Fuentes, Joffrey Pelletier, (unknown), Virginia Díez‐Obrero, (unknown), Teresa Rubio, (unknown), (unknown), Vı́ctor Moreno, Ramón Salazar, Albert Tauler, Antonio Gentilella	21
10	Nucleotide depletion reveals the impaired ribosome biogenesis checkpoint as a barrier against DNA damage 2020 ·The EMBO Journal ·Joffrey Pelletier, (unknown), Eugènia Almacellas, Caroline Mauvezin, Sara Samino, (unknown), (unknown), (unknown), (unknown), Ramón Salazar, Constanza Cortés, Ricard Marcos, Albert Tauler, Óscar Yanes, Neus Agell, Sara C. Kozma, Antonio Gentilella, George Thomas	28
11	DNA Methylation Events in Transcription Factors and Gene Expression Changes in Colon Cancer 2020 ·Epigenomics ·Anna Díez-Villanueva, Rebeca Sanz‐Pamplona, Robert Carreras‐Torres, Ferrán Moratalla-Navarro, M. Henar Alonso, Laia Paré, Susanna Aussó, Elisabet Guinó, Xavier Solé, David Cordero, Ramón Salazar, María Berdasco, Miguel A. Peinado, Vı́ctor Moreno	14
12	Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer 2019 ·Clinical Cancer Research ·(unknown), Rebeca Sanz‐Pamplona, Mireia Berdiel‐Acer, Francisco J. Cimas, Elena García García, Samuel Gonçalves-Ribeiro, (unknown), (unknown), Gabriel Capellá, Vı́ctor Moreno, Ramón Salazar, Alberto Villanueva, David G. Mollevı́	43
13	Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies 2016 ·Molecular Cancer Therapeutics ·Daniel Azuara, Cristina Santos, Adriana López‐Doriga, Julieta Grasselli, Marga Nadal, Xavier Sanjuán, (unknown), Joana Vidal, Robert Montal, Vı́ctor Moreno, Beatríz Bellosillo, Guillem Argilés, Élena Elez, Rodrigo Dienstmann, Clara Montagut, Josep Tabernero, Gabriel Capellá, Ramón Salazar	12
14	Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer 2015 ·Clinical Cancer Research ·Rebeca Sanz‐Pamplona, Adriana López‐Doriga, Laia Paré, (unknown), Fernando Bellido, M. Henar Alonso, Susanna Aussó, Elisabet Guinó, Sergi Beltrán, Francesc Castro-Giner, Marta Gut, Xavier Sanjuán, Adrià Closa, David Cordero, (unknown), Antonio Soriano, Ramón Salazar, Laura Valle, Vı́ctor Moreno	44
15	A Monotonic and Prognostic Genomic Signature from Fibroblasts for Colorectal Cancer Initiation, Progression, and Metastasis 2014 ·Molecular Cancer Research ·Mireia Berdiel‐Acer, Daniel Cuadras, (unknown), Xavier Sanjuán, Teresa Serrano, Antonio Berenguer, Vı́ctor Moreno, Samuel Gonçalves-Ribeiro, Ramón Salazar, Alberto Villanueva, David G. Mollevı́	15
16	Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial 2013 ·Clinical Cancer Research ·Josep Tabernero, Rocio García‐Carbonero, James T. Cassidy, Alberto Sobrero, Eric Van Cutsem, Claus-Henning Köhne, Sabine Tejpar, Oleg Gladkov, Ірина Давиденко, Ramón Salazar, (unknown), Sergey Cheporov, Olga Burdaeva, Fernando Rivera, Leslie Samuel, (unknown), Vanessa Potter, (unknown), Nathalie A. Lokker, Peter J. O’Dwyer	69
17	DNA Methylation Biomarkers for Noninvasive Diagnosis of Colorectal Cancer 2013 ·Cancer Prevention Research ·F. Javier Carmona, Daniel Azuara, Antonio Berenguer, Agustín F. Fernández, Sebastiano Biondo, Javier de, Francisco Rodríguez‐Moranta, Ramón Salazar, Alberto Villanueva, Mario F. Fraga, Jordi Guardiola, Gabriel Capellá, Manel Esteller, Vı́ctor Moreno	102
18	Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III) 2012 ·Journal of Clinical Oncology ·Hans‐Joachim Schmoll, David Cunningham, Alberto Sobrero, Christos S. Karapetis, Philippe Rougier, Sheryl Koski, Ilona Kocáková, Igor Bondarenko, G. Bodoky, Paul N. Mainwaring, Ramón Salazar, Peter Barker, Bijoyesh Mookerjee, Jane Robertson, Eric Van Cutsem	163
19	Gene Expression Differences between Colon and Rectum Tumors 2011 ·Clinical Cancer Research ·Rebeca Sanz‐Pamplona, David Cordero, Antonio Berenguer, Flavio Lejbkowicz, Hedy S. Rennert, Ramón Salazar, Sebastiano Biondo, Xavier Sanjuán, Miguel Ángel Pujana, Laura S. Rozek, Thomas J. Giordano, Ofer Ben‐Izhak, Hector Cohen, (unknown), (unknown), Yanina Sova, Gad Rennert, Stephen B. Gruber, Vı́ctor Moreno	70
20	Identification of MST1/STK4 and SULF1 Proteins as Autoantibody Targets for the Diagnosis of Colorectal Cancer by Using Phage Microarrays 2011 ·Molecular & Cellular Proteomics ·Ingrid Babel, Rodrigo Barderas, Ramón Díaz‐Uriarte, Vı́ctor Moreno, Adolfo Suárez, María Jesús Fernández‐Aceñero, Ramón Salazar, Gabriel Capellá, J. Ignacio Casal	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact